Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bleach-Based Autism 'Cure' In FDA Crosshairs After Comments, Recent AERs
Aug 12 2019
•
By
Malcolm Spicer
In an image included with a consumer alert, FDA leaves no doubt about its conclusions concerning the content of certain products marketed as autism "cures."
More from Regulation
More from Policy & Regulation